Literature DB >> 17922107

Urinary bladder leiomyosarcoma in adults.

Apostolos P Labanaris1, Vahudin Zugor, Bernd Meyer, Reinhold Nützel, Stephan Helmus, Panagiotis G Labanaris, Reinhard Kühn.   

Abstract

INTRODUCTION: Non-urothelial neoplasms of the bladder account for fewer than 5% of all bladder tumors. Sarcoma constitutes the most usual mesenchymal malignancy of the bladder, with leiomyosarcomas being the most common type of sarcoma in adults. PATIENTS AND METHODS: The records of seven patients presenting to two different institutions with bladder leiomyosarcomas between 2003 and 2007 and between 2000 and 2007, respectively, were examined. Cystoscopy, with transurethral resection of the bladder tumor was initially performed in all patients, with leiomyosarcoma being initially diagnosed on the basis of examination of the transurethral specimen.
RESULTS: There were N = 5 men and N = 2 women with a median age of 64.8 years at presentation. All seven patients underwent a definitive surgical procedure. Complete resection with negative surgical margins was achieved in all seven patients (100%). MSKCC stage included 86% of patients with stage 3 (N = 6) and 14% with stage 2 (N = 1). A low-grade tumor was evident in one patient only, with the remaining 86% exhibiting a high-grade tumor. DISCUSSION: Leiomyosarcomas of the bladder have always been considered as a highly aggressive entity and little is known about their origin, clinicopathologic presentation, and the survival factors associated with them. Contemporary studies suggest that these tumors may have a better prognosis than once believed. Leiomyosarcomas require aggressive surgical extirpation and, when surgical resection is possible, radical cystectomy with wide margins is the rule and should be performed. Strict adherence to standard surgical technique has resulted in low rates of positive surgical margins and low rates of local tumor recurrence.

Entities:  

Mesh:

Year:  2008        PMID: 17922107     DOI: 10.1007/s11255-007-9288-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  25 in total

Review 1.  Adult genitourinary sarcomas: a report of seventeen cases and review of the literature.

Authors:  F Berkmen; A S Celebioğlu
Journal:  J Exp Clin Cancer Res       Date:  1997-03

Review 2.  Nonepithelial neoplasms of the urinary bladder.

Authors:  B Helpap
Journal:  Virchows Arch       Date:  2001-10       Impact factor: 4.064

3.  Adult urological sarcoma.

Authors:  P Russo; M S Brady; K Conlon; S I Hajdu; W R Fair; H W Herr; M F Brennan
Journal:  J Urol       Date:  1992-04       Impact factor: 7.450

4.  Favorable long-term outcome in adult genitourinary low-grade sarcoma.

Authors:  M Froehner; A Lossnitzer; A Manseck; R Koch; B Noack; M P Wirth
Journal:  Urology       Date:  2000-09-01       Impact factor: 2.649

5.  Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.

Authors:  Scott A Martin; Donald L Sears; Thomas J Sebo; Christine M Lohse; John C Cheville
Journal:  Am J Surg Pathol       Date:  2002-03       Impact factor: 6.394

Review 6.  A systematic overview of radiation therapy effects in soft tissue sarcomas.

Authors:  Hans Strander; Ingela Turesson; Eva Cavallin-Ståhl
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

7.  Myosarcomas of the bladder and prostate.

Authors:  A R Mackenzie; W F Whitmore; M R Melamed
Journal:  Cancer       Date:  1968-10       Impact factor: 6.860

Review 8.  Leiomyosarcoma of the bladder eighteen years after cyclophosphamide therapy for retinoblastoma.

Authors:  J Kawamura; M Sakurai; K Tsukamoto; H Tochigi
Journal:  Urol Int       Date:  1993       Impact factor: 2.089

9.  Bladder leiomyosarcoma following cyclophosphamide therapy for lupus nephritis.

Authors:  J B Thrasher; G J Miller; J N Wettlaufer
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

Review 10.  Malignant non-urothelial neoplasms of the urinary bladder: a review.

Authors:  Philipp Dahm; Jürgen E Gschwend
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

View more
  8 in total

1.  Partial cystectomy: Is it a reliable option for the treatment of bladder leiomyosarcoma?

Authors:  Yun-Fei Xu; Guang-Chun Wang; Jun-Hua Zheng; Bo Peng
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

Review 2.  Leiomyosarcoma of the urinary bladder presenting as life threatening gross hematuria.

Authors:  Thomas Nelius; J Stevens; C Samathanam; S Filleur
Journal:  Med Oncol       Date:  2009-06-11       Impact factor: 3.064

3.  Non urothelial bladder cancers: a case series.

Authors:  K Ravi; Tarun Kumar; Hemang Bakshi; Janak Desai; Sanjay Sen; Vijay Yadav
Journal:  Indian J Surg Oncol       Date:  2012-08-09

4.  Urinary bladder radiotherapy-related chondroblastic osteosarcoma: Rare case report and review of literature.

Authors:  Noorah Almadani; Khaled O Alsaad; Hamoud Al-Matrafi; Abdulrahman Al Hadab; Nouf Abdullah; Abdulmohsen AlKushi
Journal:  Urol Ann       Date:  2014-07

Review 5.  Leiomyosarcoma of the urinary bladder: A review and a report of two further cases.

Authors:  Nader Y Hamadalla; Usama N Rifat; Khalid C Safi; Mustafa Mohammed; Hussam Abu-Farsakh
Journal:  Arab J Urol       Date:  2013-05-06

6.  Urinary Bladder Leiomyosarcoma: Primary Surgical Treatment.

Authors:  Hakim Slaoui; Rafael Sanchez-Salas; Pierre Validire; Eric Barret; François Rozet; Marc Galiano; Xavier Cathelineau
Journal:  Urol Case Rep       Date:  2014-07-02

7.  Organ preservation in leiomyosarcoma bladder: Case report and review of literature.

Authors:  Arun Ramdas Menon; Rajeev Thekke Puthalath; Nivedita Suresh; Suraj Hegde
Journal:  Urol Ann       Date:  2018 Apr-Jun

8.  Partial cystectomy for a primary locally advanced leiomyosarcoma of the bladder: a case report and review of the literature.

Authors:  Umesh Jayarajah; Manoj Hilary Fernando; Kasun Bandara Herath; Vipula Chandu de Silva; Serozsha Anura Sahadeva Goonewardena
Journal:  Clin Case Rep       Date:  2018-03-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.